Invention Grant
- Patent Title: Method for identification of sensitivity of a patient to telomerase inhibition therapy
-
Application No.: US14505366Application Date: 2014-10-02
-
Publication No.: US09617583B2Publication Date: 2017-04-11
- Inventor: Calvin B. Harley , Laurence Elias , Jennifer Smith , Mark J. Ratain , Fabio Benedetti
- Applicant: Geron Corporation
- Applicant Address: US CA Menlo Park
- Assignee: Geron Corporation
- Current Assignee: Geron Corporation
- Current Assignee Address: US CA Menlo Park
- Agency: Bozicevic, Field & Francis LLP
- Agent Glenn J. Foulds; Carol L. Francis
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C07H21/04 ; C12Q1/68
Abstract:
The invention provides methods for determining the susceptibility of cancer patients to developing adverse reactions if treated with a telomerase inhibitor drug by measurement of telomere length in appropriate cells of the patient prior to initiation of the telomerase inhibitor treatment.
Public/Granted literature
- US20150152488A1 Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy Public/Granted day:2015-06-04
Information query
